Actionable news
0
All posts from Actionable news
Actionable news in ABMD: ABIOMED, Inc.,

ABIOMED, Inc.

ABIOMED, Inc. reports financial results for the quarter ended June 30, 2017.We analyze the earnings along side the following peers of ABIOMED, Inc. - Boston Scientific Corporation and AtriCure, Inc. (BSX-US and ATRC-US) that have also reported for this period.

  • Summary numbers: Revenues of USD 132.47 million, Net Earnings of USD 37.37 million.
  • Gross margins narrowed from 85.37% to 83.50% compared to the same period last year, operating (EBITDA) margins now 27.03% from 22.15%.
  • Year-on-year change in operating cash flow of 37.58% is about the same as the change in earnings, likely no significant movement in accruals or reserves.
  • Earnings growth from operating margin improvements as well as one-time items.

The table below shows the preliminary results and recent trends for key metrics such as revenues and net income growth:

2017-06-302017-03-312016-12-312016-09-302016-06-30
Revenues (mil)132.5124.7114.7103103
Revenue Growth (%YOY)28.632.733.734.840.3
Earnings (mil)37.414.915.48.912.9
Earnings Growth (%YOY)189.535.546.214.745.7
Net Margin (%)28.211.913.58.612.5
EPS0.820.330.340.20.29
Return on Equity (%)7.33.43.82.33.5
Return on Assets (%)24.911.312.77.912.1

Click here to view

Spreadsheet

Spreadsheet

ABMD-US's change in revenue this period compared to the same period last year of 28.62% is almost the same as its change in...


More